10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the Quarterly Period Ended June 30, 2018

Commission File Number: 000-55144

NUTRAFUELS, INC.

(Exact name of registrant as specified in its charter)

Florida	46-1482900
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6601 Lyons Road, Suite L-6 Coconut Creek, FL  33073

(Address of principal executive offices)        (Zip Code)

   Telephone 888-509-8901

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company filer. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging Growth Company	☒

(Do not check if a smaller reporting company)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 

As of August 3, 2018, we had 89,719,069 shares of common stock outstanding.

1

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION	PAGE
Item 1. Financial Statements	F-1 to F-12
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3. Quantitative and Qualitative Disclosures About Market Risk	7
Item 4. Controls and Procedures	7
PART II-- OTHER INFORMATION
Item 1. Legal Proceedings	8
Item 1A. Risk Factors	8
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	8
Item 3. Defaults Upon Senior Securities	18
Item 4. Mine Safety Disclosures	18
Item 5. Other Information	18
Item 6. Exhibits	18
SIGNATURES	19

2

INDEX TO FINANCIAL STATEMENTS

Unaudited Condensed Consolidated Balance Sheets	F-2
Unaudited Condensed Consolidated Statements of Operations	F-3
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity	F-4
Unaudited Condensed Consolidated Statements of Changes in Cash Flows	F-5
Notes to Unaudited Condensed Consolidated Financial Statements	F-6 - F-12

F-1

NUTRAFUELS, INC.

Condensed Consolidated Balance Sheets

ASSETS	June 30, 2018	December 31, 2017
	(Unaudited)
CURRENT ASSETS
Cash and cash equivalents	$ 221,885	$ 172,948
Accounts receivable, net of allowance for doubtful accounts in the amount of $59,210	134,886	-
Inventory	474,135	162,194
Prepaid expenses and other current assets	186,074	332,460
Total current assets	1,016,980	667,602
PROPERTY AND EQUIPMENT
Furniture, fixtures and equipment	1,031,283	425,005
Leasehold improvements	498,380	154,842
Total Property and Equipment	1,529,663	579,847
Less accumulated depreciation	(379,345)	(293,317)
Property and equipment, net	1,150,318	286,530
Total Assets	$ 2,167,298	$ 954,132
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$ 311,860	$ 87,504
Accrued expenses	253,326	206,105
Customer deposits	322,178	-
Liability for shares to be issued	106,638	-
Total current liabilities	994,002	293,609
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, authorized 10,000 shares; no shares issued and        outstanding	-	-
Common stock, $0.0001 par value, authorized 499,990,000 shares; 86,767,020 and       81,448,561 issued and outstanding shares	8,677	8,144
Additional paid-in capital	34,760,647	33,411,300
Accumulated deficit	(33,596,028)	(32,758,921)
Total stockholders’ equity	1,173,296	660,523
Total Liabilities and Stockholders’ Equity	$ 2,167,298	$ 954,132

The accompanying notes are an integral part of these condensed consolidated financial statements

F-2

NUTRAFUELS, INC.

Condensed Consolidated Statements of Operations

 (Unaudited)

	For the Three Months Ended		For the Six Months Ended
	June 30, 2018	June 30, 2017	June 30, 2018		June 30, 2017
Revenue	$ 1,085,411	$ 144,759	$ 1,808,316		$ 377,398
Cost of sales	372,592	149,008	728,277		283,259
Gross Profit (Loss)	712,819	(4,249)	1,080,039		94,139
OPERATING EXPENSES:
Sales, advertising and promotion	15,813	37,162	38,174		50,885
Officer salaries	77,000	107,000	152,000		196,330
Noncash compensation	471,935	9,799,448	983,837		10,641,506
General and administrative expenses	321,164	215,288	642,225		506,809
Depreciation expense	53,171	17,305	86,028		33,219
Total operating expenses	939,084	10,176,203	1,902,265		11,428,749
LOSS FROM OPERATIONS	(226,265)	(10,180,452)	(822,226)		(11,334,610)
OTHER INCOME AND (EXPENSE)
Other income	3,609	-	3,609	-	-
Gain on settlement of debt	-	-	-		717
Induced debt conversion loss	-	-	(18,004)		(3,117,125)
Interest expense	-	(625)	(487)		(223,947)
Total other income (expense)	3,609	(625)	(14,882)		(3,340,355)
Net loss before income taxes	(222,656)	(10,181,077)	(837,108)		(14,674,965)
Income tax expense	-	-	-		-
Net loss	$ (222,656)	$ (10,181,077)	$ (837,108)		$ (14,674,965)
Loss per weighted average common
share - basic and diluted	$ (0.00)	$ (0.14)	$ (0.01)		$ (0.23)
Number of weighted average common
shares outstanding - basic and diluted	85,502,855	71,679,246	83,925,458		62,727,655

The accompanying notes are an integral part of these condensed consolidated financial statements

F-3

NUTRAFUELS, INC.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

	Number Shares Preferred	Number Shares Common	Par Amount Preferred	Par Amount Common	Additional Paid-in Capital	Accumulated Deficit	Total Stockholders’ Equity
Balance, December 31, 2016	-	45,890,912	$ -	$ 4,589	$ 7,024,608	$ (9,129,803)	$ (2,100,606)
Shares issued for cash	-	9,707,285	-	971	1,323,529	-	1,324,500
Shares issued upon exercise of options	-	275,000	-	27	54,973	-	55,000
Shares issued for debt conversion	-	10,129,942	-	1,013	5,613,858	-	5,614,871
Shares issued for prepaid services	-	1,250,000	-	125	363,875	-	364,000
Shares issued for services	-	14,195,422	-	1,420	19,030,455	-	19,031,875
Net loss	-	-	-	-	-	(23,629,117)	(23,629,117)
Balance, December 31, 2017	-	81,448,561	-	8,145	33,411,298	(32,758,920)	660,523
Shares issued to settle accounts payable	-	169,159	-	17	49,477	-	49,494
Shares issued for services	-	3,149,300	-	315	730,872	-	731,187
Shares issued to acquire fixed assets	-	2,000,000	-	200	569,000	-	569,200
Net loss	-	-	-	-	-	(837,108)	(837,108)
Balance, June 30, 2018 (unaudited)	-	86,767,020	$ -	$ 8,677	$ 34,760,647	$ (33,596,028)	$ 1,173,296

The accompanying notes are an integral part of these condensed consolidated financial statements

F-4

NUTRAFUELS, INC.

Condensed Consolidated Statements of Changes in Cash Flows

Six Months Ended June 30

(Unaudited)

	2018	2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (837,108)	$ (14,674,965)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock compensation	783,075	10,564,622
Amortization of prepaid compensation	200,762	76,884
Depreciation	86,028	33,219
Amortization of debt discount	-	531,876
Bad debt	84,183	-
Loss on stock settlement of accounts payable	18,004	-
Debt induced conversion expense	-	3,116,500
Changes in operating assets and liabilities:
(Increase) in accounts receivable	(219,069)	(104,140)
Decrease in subscription receivable	-	5,500
(Increase) decrease in inventory	(311,941)	71,216
Decrease (increase) in prepaid expenses	374	(197,365)
Increase (decrease) in accounts payable	246,829	(5,452)
Increase (decrease) in accrued expenses	33,365	(89,244)
Increase (decrease) in customer deposits	322,178	(86,100)
Net cash provided by (used) in operating activities	406,680	(757,449)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(357,743)	(29,527)
Net cash used in investing activities	(357,743)	(29,527)
CASH FLOW FROM FINANCING ACTIVITIES:
Common stock issued for cash	-	1,144,500
Cash proceeds from option exercise	-	55,000
Repayments of amounts due to related party	-	(10,000)
Net cash provided by financing activities	-	1,189,500
Net change increase in cash and cash equivalents	48,937	402,524
CASH, beginning of period	172,948	12,133
CASH, end of period	$ 221,885	$ 414,657
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash	$ 487	$ 2,043
Income taxes paid in cash	$ -	$ -
Non-Cash Financing Activities:
Property and equipment purchased with debt	$ 22,873	$ -
Shares issued to convert debt and accrued interest	$ -	$ 5,614,871
Shares issued from prior year accrual	$ -	$ 7,500
Shares issued to purchase fixed assets	$ 569,200	$ -
Shares issued to settle accounts payable	$ 49,494	$ -
Shares issued for prepaid services	$ 54,750	$ -

The accompanying notes are an integral part of these condensed consolidated financial statements

F-5

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 1 -  NATURE OF OPERATIONS

NutraFuels, Inc. (the “Company”) is the producer and distributor of nutritional supplements that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption.

NOTE 2 -  BASIS OF PRESENTATION AND USE OF ESTIMATES

a) Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States of America ("U.S.") as promulgated by the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and with the rules and regulations of the U.S Securities and Exchange Commission ("SEC"). In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the six months ended June 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.

b) Principles of Combination

The consolidated financial statements include the accounts of the Company and Precision Analytics Testing, LLC (Precision), the Company’s wholly owned subsidiary.  

c) Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

d) Cash and Equivalents

Cash equivalents are highly liquid investments with an original maturity of three months or less.  The Company had no cash equivalents at June 30, 2018 and December 31, 2017.

e) Inventories

Inventories are stated at cost utilizing the weighted average method of valuation and consist of raw materials and finished goods.The Company reduces inventory on hand to its net realizable value on an item-by-item basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the Company's inventories for such declines in value.

f) Allowance for Doubtful Accounts

We establish the existence of bad debts through a review of several factors including historical collection experience, current aging status of the customer accounts, and financial condition of our customers. The allowance for doubtful accounts at June 30, 2018 is $59,210 and $0 for the period ended June 30, 2018 and December 31, 2017, respectively.

F-6

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 2 -  BASIS OF PRESENTATION AND USE OF ESTIMATES, CONTINUED

g) Property and Equipment

All property and equipment are recorded at cost and depreciated over their estimated useful lives, generally three, seven and twelve years, using the straight-line method.  Upon sale or retirement, the cost and related accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is included in the results of operations. Repairs and maintenance charges, which do not increase the useful lives of the assets, are charged to operations as incurred.  Leasehold improvements are amortized over their estimated useful lives or the remaining term of the lease, whichever is shorter.

h) Impairment of Long-Lived Assets

A long-lived asset is tested for impairment whenever events or changes in circumstances indicate that its carrying value amount may not be recoverable. An impairment loss is recognized when the carrying amount of the asset exceeds the sum of the undiscounted cash flows resulting from its use and eventual disposition. The impairment loss is measured as the amount by which the carrying amount of the long-lived assets exceeds its fair value.

Impairment charges would be included with costs and expenses in the Company's consolidated statements of operations, and would result in reduced carrying amounts of the related assets on the Company's consolidated balance sheets. No adjustments were made to long-lived assets during the period ended June 30, 2018, as a result of management's assessments.

i) Advertising

Advertising costs are charged to operations as incurred and are included in operating expenses. The amounts charged for the six month period ended June 30, 2018 and 2017 amounted to $38,174 and $50,885, respectively.

j) Revenue Recognition

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 606, Revenue From Contracts With Customers, effective for public business entities with annual reporting periods beginning after December 15, 2017.  This new revenue recognition standard (new guidance) has a five step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. The impact of the Company’s initial application of ASC 606 did not have a material impact on its financial statements and disclosures.

The Company’s consolidated financial statements are prepared under the accrual method of accounting. Revenues are recognized when persuasive evidence of an arrangement exists, services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. This occurs only when the product is ordered and subsequently shipped.

k) Income Taxes

The Company follows the provisions of ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

F-7

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 2 -  BASIS OF PRESENTATION AND USE OF ESTIMATES, CONTINUED

k) Income Taxes, continued

Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company has no amounts accrued for interest or penalties as of June 30, 2018 and December 31, 2017, respectively.  The Company is no longer subject to examination by taxing authorities for years before December 31, 2014.  The company does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Company has received no notice of audit or any notifications from the IRS for any of the open tax years.

l) Net Loss Per Share

Basic loss per share excludes dilution and is computed by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings of the Company.  Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless consideration of such dilutive potential shares would result in anti-dilution.

m) Financial Instruments and Fair Value Measurements

The carrying value of the Company’s current consolidated financial instruments, which include cash and cash equivalents, accounts payable and accrued liabilities approximates their fair values because of the short-term maturities of these instruments.

FASB ASC 820 Fair Value Measurement clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows:

·

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date.

·

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

·

Level 3: Significant unobservable inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

o) Related Party Transactions

All transactions with related parties are in the normal course of operations and are measured at the exchange amount.

F-8

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 2 -  BASIS OF PRESENTATION AND USE OF ESTIMATES, CONTINUED

n) Recent Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, Leases which, for operating leases, requires a lessee to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight-line basis. The ASU is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2016-02 is expected to result in the recognition of right to use assets and associated obligations on its balance sheet.

NOTE 3 -  LIQUIDITY AND GOING CONCERN CONSIDERATIONS

Our consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We sustained a net loss of approximately $837,000 for the six months ended June 30, 2018, and have an accumulated deficit of approximately $33,596,000 at June 30, 2018. These conditions raise substantial doubt about our ability to continue as a going concern.

The independent auditors’ report on our consolidated financial statements for the years ended December 31, 2017  contain explanatory paragraphs expressing substantial doubt as to our ability to continue as a going concern.

Failure to successfully continue to grow operational revenues could harm our profitability and adversely affect our financial condition and results of operations. We face all of the risks inherent in a new business, including the need for significant additional capital, management’s potential underestimation of initial and ongoing costs, and potential delays and other problems in connection with establishing sales channels.

We are continuing our plan to further grow and expand operations and seek sources of capital to pay our contractual obligations as they come due. Management believes that its current operating strategy will provide the opportunity for us to continue as a going concern as long as we are able to obtain additional financing; however, there is no assurance this will occur. The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

NOTE 4 -  CONVERTIBLE DEBT

In January 2017, the Company issued 6,762,942 shares of common stock to convert $1,561,593 of convertible debt and accrued interest.  

NOTE 5 -  NOTES PAYABLE - RELATED PARTY

In January 2017, the Company issued 3,367,000 shares of common stock to convert $841,750 of debt and accrued interest to a related party.

During the first quarter 2017, we repaid $5,850 in cash to a related party on a short-term non-interest-bearing basis.

F-9

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 6 -  STOCKHOLDERS’ EQUITY

Stock Activity

At June 30, 2018 and December 31, 2017, the Company has 499,990,000 shares of $0.0001 par value common stock authorized and 86,767,020 and 81,448,561 issued and outstanding, respectively.  

In January 2018, the Company issued 900,000 shares of common stock valued at $203,351 for services.

In January 2018, the Company issued 100,000 shares of common stock valued at $47,618 for past services.

In February 2018, the Company issued 169,159 shares of common stock to settle accounts payable of $31,490. The Company recorded a loss on settlement of $18,004 in connection with this settlement.

In February 2018, the Company issued 500,000 shares of common stock valued at $140,000 for services.

In February 2018, the Company issued 2,000,000 shares of common stock valued at $569,200 for the acquisition of production equipment.

In April 2018, the Company issued 449,300 shares of common stock valued at $ 100,218 for current and on-going services.

In June 2018, the Company issued 1,200,000 shares of common stock valued at $ 240,000 for services.

Options and Warrants

Our warrants and options outstanding are:

By Exercise Price:	June 30, 2018	December 31, 2017
Warrants - $0.35	2,750,000	2,750,000
Warrants - $0.50	9,275,000	14,342,000
Warrants - $0.75	114,286	114,286
Warrants - $1.00	124,999	124,999
Total outstanding	12,264,285	17,331,285

NOTE 7 - COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company leases their office and warehouse facilities located in in Coconut Creek, Florida under a non-cancelable operating lease agreement with an expiration date of February 2019.

In June 2017, the Company entered into a new lease for an additional facility located in Deerfield Beach, Florida under a non-cancelable operating lease. The new lease begins upon substantial completion of the improvements at the facility and expires 84 months from lease commencement.

F-10

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 7 - COMMITMENTS AND CONTINGENCIES, CONTINUED

Operating Lease, continued

The following is a schedule of future minimum lease payments under all leases due in periods subsequent to June 30, 2018:

Fiscal Year Ending December 31
2018	$ 28,000
2019	167,981
2020	163,407
2021	168,310
2022	173,359
Thereafter	548,430
Total	$ 1,285,487

The Company's rental expense for all facilities and equipment amounted to $39,515 and $38,556 for the 6 month period ended June 30, 2018 and 2017, respectively.

Legal Proceedings

From time to time, the Company is subject to legal proceedings which arise in the ordinary course of the Company's business. Although there can be no assurance as to the ultimate disposition of these matters, the Company's management believes that the final disposition of such matters will not have a material adverse effect on the financial position or results of operations of the Company.

Consulting Agreements

On July 25, 2018, the Company signed a partnership and agency sales agreement (NFSKIN Agreement) with a third party entity (Revenue Sharing Partner).  The agreement calls for the non-exclusive authorization for the Revenue Sharing Partner to sell certain Company products (Protected Accounts) through their worldwide network.  The Company is to pay commissions to the Revenue Sharing Partner on sales made of those Protected Accounts.

Since the initial engagement of the Company and the Revenue Sharing Partner commenced on January 1, 2017, the calculation for the commissions owed to the Revenue Sharing Partner was calculated from January 1, 2017 through June 30, 2018. The method of payment will be in the form of shares of the Company.  As of June 30, 2018, the stock liability owed to the Revenue Sharing Partner amounted to $106,638.

NOTE 8 - CONCENTRATIONS OF CREDIT RISK

Cash and Cash Equivalents

The Company maintains its cash in bank deposit accounts with high credit quality financial institutions, which may, at times, may exceed federally insured limits. The Company had no cash balance in excess of FDIC insured limits at June 30, 2018.

Revenue

The Company’s principal customers are comprised of five separate independent private label resellers. Should the Company lose one or more of these resellers, their revenue would decline significantly.

F-11

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

NOTE 9 - SUBSEQUENT EVENTS

On July 23, 2018, 1,068,489 shares issued by the Company, with a value of $ 234,962 for past services to third party consultant were cancelled.

On July, 25, 2018, the Company issued 437,500 shares of common stock valued at $71,750 to employees of the Company as part of their compensation.

On July 25, 2018, the Company issued 514,549 shares of common stock in settlement of the liability for shares to be issued as described in Note 7.

On July, 31, 2018, the Company entered into a $250,000 convertible promissory note agreement with a private third party lender. The note bears interest at 12% and matures on July 31, 2020.  Upon execution of the note, the Company is to issue 2,000,000 shares and 625,000 warrants to purchase Company shares at a price of $.20 per share.  Additionally, at any time prior to the maturity date of the note, the third party lender can elect to convert the note into shares of the Company at $.40 per share.

F-12

NUTRAFUELS, INC.

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

CAUTIONARY NOTE FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “predict,” “project,” “forecast,” “potential,” “continue” negatives thereof or similar expressions. These forward-looking statements are found at various places throughout this Report and include information concerning possible or assumed future results of our operations; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future operations, future cash needs, business plans and future financial results, and any other statements that are not historical facts.

From time to time, forward-looking statements also are included in our other periodic reports on Form 10-K, Forms 10-Q and 8-K, in our press releases, in our presentations, on our website and in other materials released to the public. Any or all of the forward-looking statements included in this Report and in any other reports or public statements made by us are not guarantees of future performance and may turn out to be inaccurate. These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements.

In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Report. All subsequent written and oral forward-looking statements concerning other matters addressed in this Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Report.   Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

3

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the audited annual and unaudited interim Financial Statements and related notes included in this Form 10 filing, as well as the sections entitled “Risk Factors” in of this filing, as well as other cautionary statements and risks described elsewhere in this filing. Our actual results could differ materially from those discussed in the forward-looking statements

Overview

NutraFuels, Inc, a Florida corporation (“us”, “we” or “our”) was formed as a limited liability company in the state of Florida on April 1, 2010, to engage in the development and distribution of nutritional and dietary oral spray products. On December 3, 2012, we converted from a Limited Liability Company to a Florida Corporation.

We manufacture and distribute oral spray nutritional and dietary products. Our distribution strategy includes selling to private label customers retailers, distributors, and consumers through retail outlets.

Six Months Ended June 30, 2018 and 2017

We had sales of $1,808,316 and $377,398 for the six months ended June 30, 2018 and 2017, respectively, or a three hundred seventy nine point two percent (379.2%) increase. This increase resulted from greater acceptance of our products in the marketplace, which led to greater sales.

Cost of sales was $728,277 compared to $283,259 for the six months ended June 30, 2018 and 2017, respectively, or a one hundred fifty seven point one percent (157.1%) increase. This increase is directly related to our increase in sales.

Gross margin was $1,080,039 and $94,139 for the six months ended June 30, 2018 and 2017, respectively, or a one thousand forty seven point three percent (1,047.3%) increase.

General and administrative expenses were $642,225 compared to $506,809 for the six months ended June 30, 2018 and 2017, respectively, an increase of twenty six point seven percent (26.7%).

Stock based compensation was $983,837 and $10,641,506 for the six months ended June 30, 2018 and 2017, respectively, or a ninety point eight percent (90.8%) decrease. $10,462,162 of the June 30, 2017 expense was due to shares issued to our CEO under his January 2017 employment agreement with had a non-dilutive clause. This non-dilutive clause was removed in an amendment to the employment agreement in October 2017. The Company entered into several sales consulting agreements with third parties in 2018 and an agreement with its now Chief Medical Advisor, which called for shares to be issued.

Our interest expense was $487 compared to $223,947 for the six months ended June 30, 2018 and 2017, respectively, a decrease of ninety nine point eight percent (99.8%). This decrease is due to the recording of induced conversion charges upon the conversion of our debt to equity at a rate below the then prevailing market price of our stock in 2017, and in 2018 we have no debt.

We recorded a net loss of ($837,108) compared to ($14,674,965) for the six months ended June 30, 2018 and 2017, respectively.

Three Months Ended June 30, 2018 and 2017

We had sales of $1,085,411 and $144,759 for the three months ended June 30, 2018 and 2017, respectively, or a six hundred forty nine point two eight (649.8%) increase. This increase resulted from greater acceptance of our products in the marketplace during the period, which led to greater sales.

4

Cost of sales was $372,592 compared to $149,008 for the three months ended June 30, 2018 and 2017, respectively, or a one hundred fifty percent (150.0%) increase. This increase is directly related to our increase in sales.

Gross margin was $712,819 and ($4,249) for the three months ended June 30, 2018 and 2017, respectively, or a sixteen thousand eight hundred seventy six point two percent (16,876.2%) increase.

General and administrative expenses were $321,164 compared to $215,288 for the three months ended June 30, 2018 and 2017, respectively, an increase of forty nine point two percent (49.2%).

Stock based compensation was $471,935 and $9,799,448 for the three months ended June 30, 2018 and 2017, respectively, or a ninety five point two percent (95.2%) decrease.

Our interest expense was $0 compared to $625 for the three months ended June 30, 2018 and 2017, respectively, a decrease of one hundred percent (100.0%). This decrease is due to the recording of induced conversion charges upon the conversion of our debt to equity at a rate below the then prevailing market price of our stock in 2017, and in 2018 we have no debt.

We recorded a net loss of ($222,656) compared to ($10,181,077) for the three months ended June 30, 2018 and 2017, respectively.

Liquidity and Capital Resources Cash Flow Activities

Cash Flow Activities

Our cash increased $48,937 for the six months ended June 30, 2018. We generated $406,680 of cash in operating activities during the six month period.

Financing Activities

During the six months ended June 30, 2018, we funded our working capital requirements completely through our revenues, working capital and cash on hand.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires our management to make assumptions, estimates and judgments that affect the amounts reported in the financial statements, including the notes thereto, and related disclosures of commitments and contingencies, if any. We consider our critical accounting policies to be those that require the more significant judgments and estimates in the preparation of financial statements, including the following:

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

5

Fair Value of Financial Instruments

Our financial instruments consist of cash and cash equivalents, prepaid expenses, payables and accrued expenses. Fair value estimates are made at a specific point in time, based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. We consider the carrying values of our financial instruments in the consolidated financial statements to approximate fair value, due to their short-term nature.

Revenue Recognition

Revenue is recognized when earned, generally at shipment of product. Revenue is recognized on a gross basis in accordance with ASC 606.

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is provided for using straight-line methods over the estimated useful lives of the respective assets.

Valuation of Long-Lived Assets

We periodically evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset were less than the carrying value, a write-down would be recorded to reduce the related asset to its estimated fair value.

Derivatives

The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a convertible note containing an embedded derivative instrument, the instrument is marked to fair value at the conversion date and that fair value is reclassified to equity.  The shares issued upon conversion of the note are recorded at their fair value with gain or loss recognition as applicable.

Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined in Regulation S-K Item 303(a)(4).

Recent Accounting Pronouncements

(See “Recently Issued Accounting Pronouncements” in Note 2 of Notes to the Financial Statements.)

6

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Smaller reporting companies are not required to provide the information required by this item.

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s President, Chief Financial Officer, Secretary, Treasurer and Director, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure for the reasons discussed below.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal controls over financial reporting during the  six month period ending June 30, 2018 or in other factors that could significantly affect these controls, that materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

7

PART II:  OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, the Company may become involved in litigation relating to claims arising out of its operations in the normal course of business.  To the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on the Company.

Item 1A.   Risk Factors

Smaller reporting companies are not required to provide the information required by this item.

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds

On February 17, 2015, we sold a promissory note in the amount of $25,000 to Jerry O’Leary.  The note included options to purchase 25,000 of our common shares at the price of $.20 per share or an aggregate of $5,000. On January 4, 2017, Mr. O’Leary converted the amount due of $25,000 into 100,000 of our common shares at the price of $.25 per share. On February 23, 2017, we issued 25,000 shares of our common stock to Jerry O’Leary in exchange for $5,000 for the exercise of the 25,000 options.

On October 4, 2016, we sold 500,000 units to Jerry O’Leary for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 4, 2017, we sold 500,000 units to Jerry O’Leary for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On April 21, 2015, we sold a promissory note in the amount of $250,000 to William Ferri. The note accrued interest at 10% and included options to purchase 250,000 common shares at the price of $.20 per share. On January 4, 2017, William Ferri converted the principal and accrued interest due in the amount of $275,000 into our common shares at the price of $.25 per share or an aggregate of 1,100,000 shares. On May 12, 2017, Mr. Ferri exercised the 250,000 options at an exercise price of $.20 per share or an aggregate of $50,000.

On April 19, 2016, we sold a promissory note in the amount of $38,000 to Richard Scott Lohan. The note accrued interest at 10% and included warrants to purchase 100,000 common shares at the price of $.00 per share. On May 10, 2016, we repaid the principal due of $38,000. On April 19, 2016, Mr. Lohan exercised the 100,000 warrants at an exercise price of $0.00 per share or an aggregate of $0. On June 22, 2016, we sold an additional promissory note in the amount of $27,000 to Mr. Lohan. The note accrued interest at 10% and included warrants to purchase 70,000 common shares at the price of $.00 per share.  On January 4, 2017, Mr. Lohan converted the principal due of $27,000 into 270,000 common shares and accrued interest of $11,700 into 117,000 common shares at the price of $.10 per share. On June 22, 2016, Mr. Lohan exercised the 100,000 warrants at an exercise price of $0.00 per share or an aggregate of $0.

On January 5, 2017, we sold 243,000 shares to Richard Scott Lohan for the aggregate price of $12,000 or $.05 per share.

Mr. Lohan was issued 700,000 shares instead of 70,000 shares in conjunction with the exercise of the June 22, 2016 cashless warrants. He elected to convert the June 22, 2016 promissory note and accrued interest for 387,000 common shares and pay $12,000 in cash for the remaining 243,000 common shares of the 630,000 over-issuance instead of returning those shares.

8

On June 23, 2016, we amended a noted dated June 7, 2013, whereby we are obligated to pay Craig Hetherington the sum of $100,000 plus interest at the rate of 10%. Under the terms of the amended note, the note’s maturity date was July 15, 2017.

On August 27, 2016, we amended an August 26, 2013 promissory note, whereby we are obligated to pay Craig Hetherington the sum of $100,000 plus interest at the rate of 15%. Under the terms of the amended note, the note’s maturity date was July 15, 2016.

On January 4, 2017, Craig Heatherington converted principal and accrued interest due in the amount of $882,235 pursuant to a June 7, 2013 and an August 26, 2013 and a March 26, 2014 and a June 23, 2014 convertible notes into our common shares at the price of $.25 per share or an aggregate of 3,528,940 shares.

On October 22, 2015, we sold 100,000 units to James Laurain for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On November 13, 2015, we sold 100,000 units to James Laurain for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On November 25, 2015, we sold 200,000 units to James Laurain for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 10, 2015, we sold 150,000 units to James Laurain for the aggregate price of $15,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On March 9, 2016, we sold 50,000 units to James Laurain for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On March 18 2016, we sold 450,000 units to James Laurain for the aggregate price of $45,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 18, 2016, we sold 50,000 units to James Laurain for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On June 9, 2016, we sold a promissory note in the amount of $20,000 to James Laurain. The note accrued interest at 10%. On December 7, 2016, Mr. Laurain converted the principal and accrued interest due in the amount of $20,628 into our common shares at the price of $.25 per share or an aggregate of 82,512 shares.

On July 26, 2016, we sold a promissory note in the amount of $20,000 to James Laurain. The note accrued interest at 10%. On December 7, 2016, Mr. Laurain converted the principal and accrued interest due in the amount of $20,367 into our common shares at the price of $.25 per share or an aggregate of 81,468 shares.

On December 8, 2016, we sold 550,000 units to James Laurain for the aggregate price of $55,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

9

On January 3, 2017, we sold 75,000 units to James Laurain for the aggregate price of $7,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 28, 2016, we sold 250,000 units to Michael Farr for the aggregate price of $25,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On June 23, 2016, we sold a promissory note in the amount of $25,000 to Michael Farr. The note accrued interest at 10% and included 70,000 common shares. On August 23, 2016, we repaid the note and accrued interest.

On August 29, 2016, we sold a promissory note in the amount of $35,000 to Michael Farr. The note accrued interest at 10% and included 100,000 common shares. On October 12, 2016, we repaid the note and accrued interest.

On September 21, 2016, we sold a promissory note in the amount of $40,000 to Michael Farr. The note accrued interest at 10% and included 100,000 common shares. On November 21, 2016, we repaid the note and issued 160,400 common shares to Mr. Farr.

On October 13, 2016, we sold a promissory note in the amount of $60,000 to Michael Farr. The note accrued interest at 10% and included 200,000 common shares. On December 28, 2016, Mr. Farr converted the note into 660,000 common shares.

On November 23, 2016, we sold a promissory note in the amount of $65,000 to Michael Farr. The note accrued interest at 10% and included 200,000 common shares. On January 4, 2017, Mr. Farr converted the note into 300,000 common shares.

On January 6, 2017, we sold 1,300,000 units to FMG Holdings LLC for the aggregate price of $130,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 18, 2017, we sold 150,000 units to FMG Holdings LLC for the aggregate price of $30,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 28, 2017, we sold 100,000 units to FMG Holdings LLC for the aggregate price of $20,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On October 15, 2015, we sold 500,000 units to Jerry Thompson for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On November 19, 2015, we sold 200,000 units to Jerry Thompson for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 16, 2015, we sold 250,000 units to Jerry Thompson for the aggregate price of $25,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 21, 2016, we sold 150,000 units to Jerry Thompson for the aggregate price of $15,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

10

On February 5, 2016, we sold 200,000 units to Jerry Thompson for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On February 23, 2016, we sold 65,000 units to Jerry Thompson for the aggregate price of $6,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On March 4, 2016, we sold 200,000 units to Jerry Thompson for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On March 18, 2016, we sold 150,000 units to Jerry Thompson for the aggregate price of $15,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 6, 2016, we sold a promissory note in the amount of $15,000 to Jerry Thompson. The note accrued interest at 10% and included 15,000 common shares. On January 4, 2017, Mr. Thompson converted the principal and accrued interest outstanding note into 61,368 common shares.

On December 30, 2016, we sold 100,000 units to Jerry Thompson for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 3, 2017, we sold 195,000 units to Jerry Thompson for the aggregate price of $19,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On June 4, 2015, we sold 100,000 Units to G&C Investment Corp, a Florida corporation controlled by Jorge Garrido for the aggregate price of $100,000 or $1.00 per Unit. Each Unit consists of one (1) share of common stock and one (1) warrant which is exercisable into our common shares at the per share price of $.10 or an aggregate of $10,000. The warrants were exercised at the price of $.10 per share at the time of the investment.

On August 14, 2015, we entered into a promissory note, whereby we are obligated to pay Ann Noble the sum of $25,000 plus interest at the rate of 10%. Under the terms of the amended note, the note’s maturity date is August 14, 2016. The note was converted into 250,000 shares of our common stock at the price of $.10 per share on August 14, 2016.

On April 3, 2015, we issued 30,000 shares of our common stock to Barbara Ludwig for an aggregate of $6,000 or the per share price of $.20 per share.

On August 14, 2016, Barbara Ludwig converted principal due in the amount of $20,000 pursuant to an August 14, 2015 convertible note into our common shares at the price of $.10 per share or an aggregate of 200,000 shares.

On March 23, 2017, we sold 114,286 units to Barbara Ludwig for the aggregate price of $40,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 1, 2016, Dennis Poland converted principal and accrued interest due in the amount of $55,000 pursuant to a February 20, 2014 convertible note into our common shares at the price of $.10 per share or an aggregate of 550,000 shares.

11

On December 1, 2016, James Stewart converted principal and accrued interest due in the amount of $28,849.05 pursuant to an August 14, 2015 convertible note into our common shares at the price of $.10 per share or an aggregate of 287,285 shares.

On January 4, 2017, Neil Catania converted principal and accrued interest due in the amount of $841,750 pursuant to a November 15, 2012 and July 26, 2016 convertible notes and a December 31, 2013 line of credit into our common shares at the price of $.25 per share or an aggregate of 3,367,000 shares. On December 1, 2016, we issued 2,000,000 shares to Neil Catania, VP of the Company, for services rendered. We valued these shares at $.06 per share or an aggregate of $120,000.00.

On January 4, 2017, John Hampton converted principal and accrued interest due in the amount of $147,583 pursuant to an August 27, 2014 and an October 3, 2014 convertible notes into our common shares at the price of $.25 per share or an aggregate of 590,332 shares.

On January 4, 2017, Michael Smyth converted principal and accrued interest due in the amount of $70,680 pursuant to a November 15, 2012 convertible note into our common shares at the price of $.25 per share or an aggregate of 282,720 shares.

On January 4, 2017, Donald Brennick converted principal and accrued interest due in the amount of $28,395 pursuant to an August 26, 2015 convertible note into our common shares at the price of $.10 per share or an aggregate of 283,950 shares.

On January 30, 2017, we issued 250,000 shares to Bernadine Cawley for services rendered to us. We valued these shares at $.40 per share or an aggregate of $100,000.00.

On May 10, 2017, we sold 375,000 units to Bernadine Cawley for the aggregate price of $75,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $0.50 at any time until the two (2) year anniversary of the date of the investment.

On October 13, 2015, we sold 100,000 units to Tom and Carol Perrine for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On November 17, 2015, we sold 100,000 units to Tom and Carol Perrine for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 29, 2016, we sold 100,000 units to Tom and Carol Perrine for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On October 22, 2015, we sold 102,000 units to Alan Maurer for the aggregate price of $10,200 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On October 22, 2015, we sold 50,000 units to Gordon Langston for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 9, 2017, we sold 250,000 units to Gordon Langston for the aggregate price of $25,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

12

On November 5, 2015, we sold 50,000 units to Barclay Armitage for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 8, 2016, we sold 75,000 units to Barclay Armitage for the aggregate price of $7,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On November 17, 2015, we sold 50,000 units to Michael Ward for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 7, 2015, we sold 50,000 units to David Knudtson for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 15, 2015, we sold 200,000 units to William Rodriguez for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment. On January 9, 2017, we sold 405,000 units to William Rodriguez for the aggregate price of $40,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment. On January 17, 2017, we sold 200,000 units to William Rodriguez for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On December 15, 2015, we sold 50,000 units to Nathaniel Rodriguez for the aggregate price of $5,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On February 19, 2016, we sold 75,000 units to Kerry McDonald for the aggregate price of $7,500 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On February 23, 2016, we sold 250,000 units to Thomas Jacobsen for the aggregate price of $25,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On April 5, 2016, we sold 100,000 units to Laura & Anthony Suttora for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 2, 2016, we sold 200,000 units to Anthony Monteleone for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 6, 2016, we sold 100,000 units to Leon English for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment. On January 7, 2017, we sold 100,000 units to Leon English for the aggregate price of $10,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

13

On June 1, 2016, we sold 400,000 units to Dominant Holdings LLC, a Massachusetts limited liability company controlled by Kelly Benson, for the aggregate price of $40,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $0.50 at any time until the two (2) year anniversary of the date of the investment.

On July 16, 2016, we sold 400,000 units to Dominant Holdings LLC for the aggregate price of $40,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On August 1, 2016, we sold 300,000 units to Dominant Holdings LLC for the aggregate price of $30,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On August 19, 2016, we sold 300,000 units to Dominant Holdings LLC for the aggregate price of $30,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 25, 2016, we sold 150,000 units to John Berning for the aggregate price of $15,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 20, 2017, we sold 150,000 units to John Berning for the aggregate price of $15,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 27, 2016, we sold 500,000 units to Paul & Cheryl Botts for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 11, 2017, we sold 500,000 units to Paul & Cheryl Botts for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 6, 2017, we sold 500,000 units to Jeff Luccesi for the aggregate price of $50,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 6, 2017, we sold 300,000 units to STF Partners, LP, a New York limited partnership controlled by Sharyn Frankel, for the aggregate price of $30,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $0.50 at any time until the two (2) year anniversary of the date of the investment.

On January 6, 2017, we sold 200,000 units to Breadfruit Tree Inc., a Florida corporation, doing business as NF Skin, our distributor, and controlled by F. Bruce Hutson, for the aggregate price of $20,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On January 9, 2017, we sold 300,000 units to Davis Pallen for the aggregate price of $30,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

14

On January 9, 2017, we sold 1,500,000 units to Forage Complete LLC, an Idaho limited liability company controlled by Cody Jensen, for the aggregate price of $150,000 or $.10 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 17, 2017, we sold 200,000 units to Forage Complete LLC for the aggregate price of $40,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 28, 2017, we sold 100,000 units to Forage Complete LLC for the aggregate price of $20,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On February 23, 2017, we sold 41,666 units to Patricia Gleason for the aggregate price of $25,000 or $.60 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On February 23, 2017, we sold 83,333 units to David Corcoran for the aggregate price of $50,000 or $.60 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On April 24, 2017, we sold 500,000 units to Gregory Ross for the aggregate price of $100,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 21, 2017, we sold 50,000 units to James Rutledge for the aggregate price of $10,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On May 24, 2017, we sold 575,000 units to EW Strategies LLC, a Georgia limited liability company controlled by Greg Schantz, for the aggregate price of $115,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On July 7, 2017, we sold 250,000 units to Wolbers Family Trust, a trust controlled by Jennifer Wolbers, for the aggregate price of $50,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $0.50 at any time until the two (2) year anniversary of the date of the investment.

On July 19, 2017, we sold 150,000 units to Peter Mazza for the aggregate price of $30,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On August 1, 2017, we sold 50,000 units to David Dickman for the aggregate price of $10,000 or $.20 per unit. Each unit consists of one (1) share of common stock and one (1) warrant to purchase one (1) share of common stock at the price of $.50 at any time until the two (2) year anniversary of the date of the investment.

On October 1, 2015, we issued 30,000 of our common stock to Peter Cianci in exchange for services rendered. We valued these shares at the price of $.17 per share or an aggregate of $5,10.

On October 1, 2015, we issued 40,000 shares to Five Star Labs, LLC, a Florida limited liability company controlled by Eric Caprarese for services rendered. We valued these shares at $.17 per share or an aggregate of $6,800.00.

15

On October 1, 2015, we issued 1,000,000 shares to Osprey Capital Advisors, LLC a Florida limited liability company controlled by Terence M. Taylor, for services rendered. We valued these shares at $.183 per share or an aggregate of $183,000.00.

On December 1, 2015, we issued 1,000,000 shares to Osprey Capital Advisors, LLC a Florida limited liability company controlled by Terence M. Taylor, for services rendered. We valued these shares at $.122 per share or an aggregate of $122,000.00.

On December 16, 2015 and January 2, 2016, we issued 75,000 shares to WT Consulting, LLC a Florida limited liability company controlled by William Hirschy, for services rendered. We valued these shares at $.3467 per share or an aggregate of $52,000.  

On January 4, 2016, we issued 100,000 shares to Patagonia Global Trading, LLC, a Florida limited liability company controlled by David Zirulnikoff, for services rendered. We valued these shares at $.10 per share or an aggregate of $10,000.00.

On January 2, 2017, we issued 50,000 shares to Patagonia Global Trading, a Florida entity, for services rendered. We valued these shares at $.25 per share or an aggregate of $12,500.00.

On June 9, 2016, we issued Josh Zwagil 244,514 shares for new business development. We valued these shares at $.11 per share, or an aggregate of $26,896.54.

On December 1, 2016, we issued 4,000,000 shares to Edgar Ward, CEO of the Company, for services rendered. We valued these shares at $.06 per share or an aggregate of $240,000.00. On March 3, 2017, we issued 7,220,585 shares to Edgar Ward, CEO of the Company, for services rendered. We valued these shares at $1.45 per share or an aggregate of $10,453,315. On November 27, 2017, we issued 6,674,837 shares to Edgar Ward, CEO of the Company, for services rendered. We valued these shares at $1.27 per share or an aggregate of $8,464,463.

On December 1, 2016, we issued 1,000,000 shares to Nicole Archon for services rendered. We valued these shares at $.06 per share or an aggregate of $60,000.00.

On December 14, 2016, we issued 249,999 shares to Venture Capital Group, LLC a Delaware limited liability company controlled by William Stern, for services rendered. We valued these shares at an aggregate $.0972 per share or an aggregate of $24,300.00.

On January 17, 2017, we issued 100,000 shares to Hamilton & Associates Law Group a Florida law firm controlled by Brenda Hamilton, Esq., for services rendered. We valued these shares at an aggregate $.10 per share or an aggregate of $10,000.00.

On January 30, 2017, we issued 400,000 shares to Anthony Procelli, for services rendered. We valued these shares at $.40 per share or an aggregate of $160,000.00.

On January 30, 2017, we issued 50,000 shares to Patrick Kilcooley, for services rendered. We valued these shares at $.40 per share or an aggregate of $20,000.00.

On January 30, 2017, we issued 300,000 shares to Daniel Ryan, for services rendered. We valued these shares at $.40 per share or an aggregate of $120,000.00.

On February 1, 2017, we issued 50,000 shares to Sylvan Eudes, for services rendered. We valued these shares at $.12 per share or an aggregate of $6,000.00.

On April 10, 2017, we issued 250,000 shares of our restricted common stock to Michael R. Anderson for services rendered. We valued these shares at $.69 per share or an aggregate of $172,500.00.

16

On July 17, 2017, we issued 100,000 shares to Kenneth Duchin, for services rendered. We valued these shares at $.80 per share or an aggregate of $80,000.00.

On December 17, 2017, we issued 500,000 shares Hongxiang Hui for services rendered to us. We valued these shares at $.15 and $.10 per share.

On February 15, 2018, we issued 2,000,000 shares to Hall Global LLC, a limited liability controlled by Michael Anderson for equipment provided to us. We valued these shares at $.2846 per share or an aggregate of $569,200.

On January 23, 2018, we issued 200,000 common shares to Randy Avon for services rendered to us. We valued these shares at $.21 per share or an aggregate of $41,446.

On January 23, 2018, we issued 150,000 common shares to Daniel Slane for services rendered to us. We valued these shares at $.21 per share or an aggregate of $31,085.

On January 23, 2018, we issued 100,000 common shares to Michel Lohan for services rendered to us. We valued these shares at $.4762 per share or an aggregate of $47,618.

On January 23, 2018, we issued 350,000 shares David Zirulnikoff for services rendered to us. We valued these shares at $.26 per share or an aggregate of $89,374.

On January 23, 2018, we issued 200,000 common shares to Ronald Silver for services rendered to us. We valued these shares at $.21per share or an aggregate of $41,446.

On February 15, 2018, we issued 500,000 common shares to Hongxiang Hui for services rendered to us. We valued these shares at $.28 per share or an aggregate of $140,000.

On January 5, 2018, February 26, 2018, April 11, 2018, April 20, 2018 and June 2, 2018, we issued 43,759, 125,400, 51,700, 147,600 and 700,000 shares of our common stock to Hamilton & Associates Law Group, P.A. for services rendered which we valued these shares at $.30, $.29, $.18 $.245 and $.20 per share, respectively.

On May 11, 2018, we issued 250,000 common shares to Tony Hunter for services rendered to us. We valued these shares at $.19 per share or an aggregate of $ 54,750.

On June 1, 2018, we issued 500,000 common shares to Lyons Capital for services rendered to us. We valued these shares at $.20 per share or an aggregate of $100,000.

On July 25, 2018, we issued 62,500 common shares to Mary Ellen Mahon for services rendered to us. We valued these shares at $.16 per share or an aggregate of $10,250.

On July 25, 2018, we issued 62,500 common shares to Anthony Centorani for services rendered to us. We valued these shares at $.16 per share or an aggregate of $10,250.

On July 25, 2018, we issued 250,000 common shares to Michael P. Dulak for services rendered to us. We valued these shares at $.16 per share or an aggregate of $41,000.

On July 25, 2018, we issued 62,500 common shares to Robert Patrick Scott for services rendered to us. We valued these shares at $.16 per share or an aggregate of $10,250.

On July 25, 2018, we entered into an agreement with Breadfruit Tree DBA NFSkin, a Florida corporation where by we agreed to pay them 15% of their net sales of our product. The 15% is payable in up to 3,000,000 shares of our common stock which will be calculated based on a value of $.20 per share. On August 9, 2018, we issued 514,549 of the shares issuable under the agreement.

17

On July 31, 2018, we entered into a note agreement with New Leaf Assets, LLC, a Delaware limited liability company. The note bears interest at the rate of 12%. In connection with the note, New Leaf received 2,000,000 shares of our common stock and 625,000 warrants exercisable at the rate of $.20 per share at any time until July 31, 2021.  The principal and accrued interest due under the note is convertible at the holder’s option into our common shares at the price of $.40 per share at any time prior to maturity.

Item 3.     Defaults Upon Senior Securities

None.

Item 4.     Mine Safety Disclosures

Not applicable.

Item 5.    Other Information

None.

Item 6.    Exhibits

Exhibit No.

Description

31.1*

Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of Sarbanes Oxley Act of 2002

32.1*

Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes Oxley Act of 2002

* Filed herewith.

18

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

NutraFuels, Inc.

Date: August 14, 2018	By:	/s/ Edgar Ward
		Edgar Ward President, Chief Executive Officer, Acting Chief Financial Officer and Treasurer (Principal Executive Officer and Principal Financial Officer)

19

EX-31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Edgar Ward, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of NutraFuels, Inc, for the period ending June 30, 2018;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.    Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)

all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 14, 2018	By:	/s/ Edgar Ward
		Edgar Ward President, Chief Executive Officer, Acting Chief Financial Officer and Treasurer (Principal Executive Officer and Principal Financial Officer)

EX-32.1

SECTION 906 CERTIFICATION 
NutraFuels, Inc.

I certify that, to the best of my knowledge and belief, the Quarterly Report on Form 10-Q of NutraFuels, Inc. for the period ending June 30, 2018 (the “Report”):

(1)

complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of NutraFuels, Inc.

Date: August 14, 2018	By:	/s/ Edgar Ward
		Edgar Ward President, Chief Executive Officer, Acting Chief Financial Officer and Treasurer (Principal Executive Officer and Principal Financial Officer)

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2018 shares
Document and Entity Information:
Entity Registrant Name	NUTRAFUELS INC
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Entity Central Index Key	0001563463
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding	86,767,020
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Trading Symbol	ntfl

XML

NUTRAFUELS, INC. - Balance Sheets - USD ($)		Jun. 30, 2018	Dec. 31, 2017
Current Assets:
Cash		$ 221,885	$ 172,948
Accounts receivable	[1]	134,886
Inventory		474,135	162,194
Prepaid expenses and other current assets		186,074	332,460
TOTAL CURRENT ASSETS		1,016,980	667,602
PROPERTY AND EQUIPMENT
Furniture, fixtures and equipment		1,031,283	425,005
Leasehold improvements		498,380	154,842
Total Property and Equipment		1,529,663	579,847
Less accumulated depreciation		(379,345)	(293,317)
Property and equipment, net		1,150,318	286,530
Total Assets		2,167,298	954,132
Current Liabilities:
Accounts payable		311,860	87,504
Accrued expenses		253,326	206,105
Customer deposits		322,178
Liability for shares to be issued		106,638
Total Current Liabilities		994,002	293,609
Stockholders' Equity
Preferred stock
Common stock		8,677	8,144
Additional paid-in capital		34,760,647	33,411,300
Accumulated deficit		(33,596,028)	(32,758,921)
TOTAL STOCKHOLDERS' EQUITY		1,173,296	660,523
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$ 2,167,298	$ 954,132

[1] Net of allowance for doubtful accounts in the amount of $59,210

XML

Statement of Financial Position - Parenthetical - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000	10,000
Preferred Stock, Shares Issued	1,000	1,000
Preferred Stock, Shares Outstanding	1,000	1,000
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	499,990,000	499,990,000
Common Stock, Shares Issued	86,767,020	81,448,561
Common Stock, Shares Outstanding	86,767,020	81,448,561

XML

NUTRAFUELS, INC. - Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement
Revenue	$ 1,085,411	$ 144,759	$ 1,808,316	$ 377,398
Cost of sales	372,592	149,008	728,277	283,259
Gross Profit (Loss)	712,819	(4,249)	1,080,039	94,139
OPERATING EXPENSES:
Sales, advertising and promotion	15,813	37,162	38,174	50,885
Officer salaries	77,000	107,000	152,000	196,330
Noncash compensation	471,935	9,799,448	983,837	10,641,506
General and administrative expenses	321,164	215,288	642,225	506,809
Depreciation expense	53,171	17,305	86,028	33,219
Total operating expenses	939,084	10,176,203	1,902,265	11,428,749
LOSS FROM OPERATIONS	(226,265)	(10,180,452)	(822,226)	(11,334,610)
OTHER INCOME (EXPENSE)
Other income	3,609		3,609
Gain on settlement of debt				717
Induced debt conversion loss			(18,004)	(3,117,125)
Interest expense		(625)	(487)	(223,947)
Total other income (expense)	3,609	(625)	(14,882)	(3,340,355)
Net loss before income taxes	(222,656)	(10,181,077)	(837,108)	(14,674,965)
Income tax expense
Net loss	$ (222,656)	$ (10,181,077)	$ (837,108)	$ (14,674,965)
Net loss per weighted average common share - basic and diluted	$ (0.00)	$ (0.14)	$ (0.01)	$ (0.23)
Number of weighted average common shares outstanding - basic and diluted	85,502,855	71,679,246	83,925,458	62,727,655

XML

NUTRAFUELS, INC. - Statements of Changes in Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss	$ (837,108)	$ (14,674,965)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock compensation	783,075	10,564,622
Amortization of prepaid compensation	200,762	76,884
Depreciation	86,028	33,219
Amortization of debt discount		531,876
Bad debt	84,183
Loss on stock settlement of accounts payable	18,004
Debt induced conversion expense		3,116,500
Changes in operating assets and liabilities:
(Increase) in accounts receivable	(219,069)	(104,140)
Decrease in subscription receivable		5,500
(Increase) decrease in inventory	(311,941)	71,216
Decrease (increase) in prepaid expenses	374	(197,365)
Increase (decrease) in accounts payable	246,829	(5,452)
Increase (decrease) in accrued expenses	33,365	(89,244)
Increase (decrease) in customer deposits	322,178	(86,100)
Net Cash provided by (used in) Operating Activities	406,680	(757,449)
Cash Flows From Investing Activities:
Purchase of property and equipment	(357,743)	(29,527)
Net Cash used in Investing Activities	(357,743)	(29,527)
Cash Flows From Financing Activities:
Common stock issued for cash		1,144,500
Cash proceeds from option exercise		55,000
Repayments of amounts due to related party		(10,000)
Net Cash provided by Financing Activities		1,189,500
Net change increase in cash and cash equivalents	48,937	402,524
Cash, beginning of period	172,948	12,133
Cash, end of period	221,885	414,657
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash	487	2,043
Income taxes paid in cash
Non-Cash Financing Activities:
Property and equipment purchased with debt	22,873
Shares issued to convert debt and accrued interest		5,614,871
Shares issued from prior year accrual		$ 7,500
Shares issued to purchase fixed assets	569,200
Shares issued to settle accounts payable	49,494
Shares issued for prepaid services	$ 54,750

XML

Note 1 - Nature of Operations

6 Months Ended

Jun. 30, 2018

Notes

Note 1 - Nature of Operations

NOTE 1 -  NATURE OF OPERATIONS

NutraFuels, Inc. (the “Company”) is the producer and distributor of nutritional supplements that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption.

XML

Note 2 - Basis of Presentation and Use of Estimates

6 Months Ended

Jun. 30, 2018

Notes

Note 2 - Basis of Presentation and Use of Estimates

NOTE 2 -  BASIS OF PRESENTATION AND USE OF ESTIMATES

a) Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States of America ("U.S.") as promulgated by the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and with the rules and regulations of the U.S Securities and Exchange Commission ("SEC"). In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the six months ended June 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.

b) Principles of Combination

The consolidated financial statements include the accounts of the Company and Precision Analytics Testing, LLC (Precision), the Company’s wholly owned subsidiary. 

c) Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

d) Cash and Equivalents

Cash equivalents are highly liquid investments with an original maturity of three months or less.  The Company had no cash equivalents at June 30, 2018 and December 31, 2017.

e) Inventories

Inventories are stated at cost utilizing the weighted average method of valuation and consist of raw materials and finished goods.The Company reduces inventory on hand to its net realizable value on an item-by-item basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the Company's inventories for such declines in value.

f) Allowance for Doubtful Accounts

We establish the existence of bad debts through a review of several factors including historical collection experience, current aging status of the customer accounts, and financial condition of our customers. The allowance for doubtful accounts at June 30, 2018 is $59,210 and $0 for the period ended June 30, 2018 and December 31, 2017, respectively.

g) Property and Equipment

All property and equipment are recorded at cost and depreciated over their estimated useful lives, generally three, seven and twelve years, using the straight-line method.  Upon sale or retirement, the cost and related accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is included in the results of operations. Repairs and maintenance charges, which do not increase the useful lives of the assets, are charged to operations as incurred.  Leasehold improvements are amortized over their estimated useful lives or the remaining term of the lease, whichever is shorter.

h) Impairment of Long Lived Assets

A long lived asset is tested for impairment whenever events or changes in circumstances indicate that its carrying value amount may not be recoverable. An impairment loss is recognized when the carrying amount of the asset exceeds the sum of the undiscounted cash flows resulting from its use and eventual disposition. The impairment loss is measured as the amount by which the carrying amount of the long lived assets exceeds its fair value.

Impairment charges would be included with costs and expenses in the Company's consolidated statements of operations, and would result in reduced carrying amounts of the related assets on the Company's consolidated balance sheets. No adjustments were made to long-lived assets during the period ended June 30, 2018, as a result of management's assessments.

i) Advertising

Advertising costs are charged to operations as incurred and are included in operating expenses. The amounts charged for the six month period ended June 30, 2018 and 2017 amounted to $38,174 and $50,885, respectively.

j) Revenue Recognition

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 606, Revenue From Contracts With Customers, effective for public business entities with annual reporting periods beginning after December 15, 2017.  This new revenue recognition standard (new guidance) has a five step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. The impact of the Company’s initial application of ASC 606 did not have a material impact on its financial statements and disclosures.

The Company’s consolidated financial statements are prepared under the accrual method of accounting. Revenues are recognized when persuasive evidence of an arrangement exists, services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. This occurs only when the product is ordered and subsequently shipped.

k) Income Taxes

The Company follows the provisions of ASC 740 10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740 10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company has no amounts accrued for interest or penalties as of June 30, 2018 and December 31, 2017, respectively.  The Company is no longer subject to examination by taxing authorities for years before December 31, 2014.  The company does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Company has received no notice of audit or any notifications from the IRS for any of the open tax years.

l) Net Loss Per Share

Basic loss per share excludes dilution and is computed by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings of the Company.  Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless consideration of such dilutive potential shares would result in anti-dilution.

m) Financial Instruments and Fair Value Measurements

The carrying value of the Company’s current consolidated financial instruments, which include cash and cash equivalents, accounts payable and accrued liabilities approximates their fair values because of the short term maturities of these instruments.

FASB ASC 820 Fair Value Measurement clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows:

• Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date.
• Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
• Level 3: Significant unobservable inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

o) Related Party Transactions

All transactions with related parties are in the normal course of operations and are measured at the exchange amount.

n) Recent Accounting Pronouncements

In February 2016, the FASB issued ASU 2016 02, Leases which, for operating leases, requires a lessee to recognize a right of use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight line basis. The ASU is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2016 02 is expected to result in the recognition of right to use assets and associated obligations on its balance sheet.

XML

Note 3 - Liquidity and Going Concern Considerations

6 Months Ended

Jun. 30, 2018

Notes

Note 3 - Liquidity and Going Concern Considerations

NOTE 3 -  LIQUIDITY AND GOING CONCERN CONSIDERATIONS

Our consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We sustained a net loss of approximately $837,000 for the six months ended June 30, 2018, and have an accumulated deficit of approximately $33,596,000 at June 30, 2018. These conditions raise substantial doubt about our ability to continue as a going concern.

The independent auditors’ report on our consolidated financial statements for the years ended December 31, 2017 contain explanatory paragraphs expressing substantial doubt as to our ability to continue as a going concern.

Failure to successfully continue to grow operational revenues could harm our profitability and adversely affect our financial condition and results of operations. We face all of the risks inherent in a new business, including the need for significant additional capital, management’s potential underestimation of initial and ongoing costs, and potential delays and other problems in connection with establishing sales channels.

We are continuing our plan to further grow and expand operations and seek sources of capital to pay our contractual obligations as they come due. Management believes that its current operating strategy will provide the opportunity for us to continue as a going concern as long as we are able to obtain additional financing; however, there is no assurance this will occur. The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

XML

Note 4 - Convertible Debt

6 Months Ended

Jun. 30, 2018

Notes

Note 4 - Convertible Debt

NOTE 4 -  CONVERTIBLE DEBT

In January 2017, the Company issued 6,762,942 shares of common stock to convert $1,561,593 of convertible debt and accrued interest. 

XML

Note 5 - Notes Payable - Related Party

6 Months Ended

Jun. 30, 2018

Notes

Note 5 - Notes Payable - Related Party

NOTE 5 -  NOTES PAYABLE - RELATED PARTY

In January 2017, the Company issued 3,367,000 shares of common stock to convert $841,750 of debt and accrued interest to a related party.

During the first quarter 2017, we repaid $5,850 in cash to a related party on a short-term non-interest-bearing basis.

XML

Note 6 - Stockholders' Equity

6 Months Ended

Jun. 30, 2018

Notes

Note 6 - Stockholders' Equity

NOTE 6 -  STOCKHOLDERS’ EQUITY

Stock Activity

At June 30, 2018 and December 31, 2017, the Company has 499,990,000 shares of $0.0001 par value common stock authorized and 86,767,020 and 81,448,561 issued and outstanding, respectively. 

In January 2018, the Company issued 900,000 shares of common stock valued at $203,351 for services.

In January 2018, the Company issued 100,000 shares of common stock valued at $47,618 for past services.

In February 2018, the Company issued 169,159 shares of common stock to settle accounts payable of $31,490. The Company recorded a loss on settlement of $18,004 in connection with this settlement.

In February 2018, the Company issued 500,000 shares of common stock valued at $140,000 for services.

In February 2018, the Company issued 2,000,000 shares of common stock valued at $569,200 for the acquisition of production equipment.

In April 2018, the Company issued 449,300 shares of common stock valued at $100,218 for current and on-going services.

In June 2018, the Company issued 1,200,000 shares of common stock valued at $240,000 for services.

Options and Warrants

Our warrants and options outstanding are:

By Exercise Price:	June 30, 2018	December 31, 2017
Warrants - $0.35	2,750,000	2,750,000
Warrants - $0.50	9,275,000	14,342,000
Warrants - $0.75	114,286	114,286
Warrants - $1.00	124,999	124,999
Total outstanding	12,264,285	17,331,285

XML

Note 7 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2018

Notes

Note 7 - Commitments and Contingencies

NOTE 7 - COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company leases their office and warehouse facilities located in in Coconut Creek, Florida under a non-cancelable operating lease agreement with an expiration date of February 2019.

In June 2017, the Company entered into a new lease for an additional facility located in Deerfield Beach, Florida under a non-cancelable operating lease. The new lease begins upon substantial completion of the improvements at the facility and expires 84 months from lease commencement.

The following is a schedule of future minimum lease payments under all leases due in periods subsequent to June 30, 2018:

Fiscal Year Ending December 31
2018	$     116,657
2019	28,000
2020	167,981
2021	163,417
2022	168,310
Thereafter	548,430
Total	$ 1,285,487

The Company's rental expense for all facilities and equipment amounted to $39,515 and $38,556 for the 6 month period ended June 30, 2018 and 2017, respectively.

Legal Proceedings

From time to time, the Company is subject to legal proceedings which arise in the ordinary course of the Company's business. Although there can be no assurance as to the ultimate disposition of these matters, the Company's management believes that the final disposition of such matters will not have a material adverse effect on the financial position or results of operations of the Company.

Consulting Agreements

On July 25, 2018, the Company signed a partnership and agency sales agreement (NFSKIN Agreement) with a third party entity (Revenue Sharing Partner).  The agreement calls for the non-exclusive authorization for the Revenue Sharing Partner to sell certain Company products (Protected Accounts) through their worldwide network.  The Company is to pay commissions to the Revenue Sharing Partner on sales made of those Protected Accounts.

Since the initial engagement of the Company and the Revenue Sharing Partner commenced on January 1, 2017, the calculation for the commissions owed to the Revenue Sharing Partner was calculated from January 1, 2017 through June 30, 2018. The method of payment will be in the form of shares of the Company.  As of June 30, 2018, the stock liability owed to the Revenue Sharing Partner amounted to $106,638.

XML

Note 8 - Concentrations of Credit Risk

6 Months Ended

Jun. 30, 2018

Notes

Note 8 - Concentrations of Credit Risk

NOTE 8 - CONCENTRATIONS OF CREDIT RISK

Cash and Cash Equivalents

The Company maintains its cash in bank deposit accounts with high credit quality financial institutions, which may, at times, may exceed federally insured limits. The Company had no cash balance in excess of FDIC insured limits at June 30, 2018.

Revenue

The Company’s principal customers are comprised of five separate independent private label resellers. Should the Company lose one or more of these resellers, their revenue would decline significantly.

XML

Note 9 - Subsequent Events

6 Months Ended

Jun. 30, 2018

Notes

Note 9 - Subsequent Events

NOTE 9 - SUBSEQUENT EVENTS

On July 23, 2018, 1,068,489 shares issued by the Company, with a value of $234,962 for past services to third party consultant were cancelled.

On July, 25, 2018, the Company issued 437,500 shares of common stock valued at $71,750 to employees of the Company as part of their compensation.

On July 25, 2018, the Company issued 514,549 shares of common stock in settlement of the liability for shares to be issued as described in Note 7.

On July, 31, 2018, the Company entered into a $250,000 convertible promissory note agreement with a private third party lender. The note bears interest at 12% and matures on July 31, 2020.  Upon execution of the note, the Company is to issue 2,000,000 shares and 625,000 warrants to purchase Company shares at a price of $.20 per share.  Additionally, at any time prior to the maturity date of the note, the third party lender can elect to convert the note into shares of the Company at $.40 per share.

XML

Note 2 - Basis of Presentation and Use of Estimates: A) Basis of Presentation (Policies)

6 Months Ended

Jun. 30, 2018

Policies

A) Basis of Presentation

a) Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States of America ("U.S.") as promulgated by the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and with the rules and regulations of the U.S Securities and Exchange Commission ("SEC"). In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the six months ended June 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018.

XML

Note 2 - Basis of Presentation and Use of Estimates: B) Principles of Combination (Policies)

6 Months Ended

Jun. 30, 2018

Policies

B) Principles of Combination

b) Principles of Combination

The consolidated financial statements include the accounts of the Company and Precision Analytics Testing, LLC (Precision), the Company’s wholly owned subsidiary. 

XML

Note 2 - Basis of Presentation and Use of Estimates: C) Use of Estimates (Policies)

6 Months Ended

Jun. 30, 2018

Policies

C) Use of Estimates

c) Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

XML

Note 2 - Basis of Presentation and Use of Estimates: D) Cash and Equivalents (Policies)

6 Months Ended

Jun. 30, 2018

Policies

D) Cash and Equivalents

d) Cash and Equivalents

Cash equivalents are highly liquid investments with an original maturity of three months or less.  The Company had no cash equivalents at June 30, 2018 and December 31, 2017.

XML

Note 2 - Basis of Presentation and Use of Estimates: E) Inventories (Policies)

6 Months Ended

Jun. 30, 2018

Policies

E) Inventories

e) Inventories

Inventories are stated at cost utilizing the weighted average method of valuation and consist of raw materials and finished goods.The Company reduces inventory on hand to its net realizable value on an item-by-item basis when it is apparent that the expected realizable value of an inventory item falls below its original cost. A charge to cost of sales results when the estimated net realizable value of specific inventory items declines below cost. Management regularly reviews the Company's inventories for such declines in value.

XML

Note 2 - Basis of Presentation and Use of Estimates: F) Allowance For Doubtful Accounts (Policies)

6 Months Ended

Jun. 30, 2018

Policies

F) Allowance For Doubtful Accounts

f) Allowance for Doubtful Accounts

We establish the existence of bad debts through a review of several factors including historical collection experience, current aging status of the customer accounts, and financial condition of our customers. The allowance for doubtful accounts at June 30, 2018 is $59,210 and $0 for the period ended June 30, 2018 and December 31, 2017, respectively.

XML

Note 2 - Basis of Presentation and Use of Estimates: G) Property and Equipment (Policies)

6 Months Ended

Jun. 30, 2018

Policies

G) Property and Equipment

g) Property and Equipment

All property and equipment are recorded at cost and depreciated over their estimated useful lives, generally three, seven and twelve years, using the straight-line method.  Upon sale or retirement, the cost and related accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is included in the results of operations. Repairs and maintenance charges, which do not increase the useful lives of the assets, are charged to operations as incurred.  Leasehold improvements are amortized over their estimated useful lives or the remaining term of the lease, whichever is shorter.

XML

Note 2 - Basis of Presentation and Use of Estimates: H) Impairment of Long lived Assets (Policies)

6 Months Ended

Jun. 30, 2018

Policies

H) Impairment of Long lived Assets

h) Impairment of Long Lived Assets

A long lived asset is tested for impairment whenever events or changes in circumstances indicate that its carrying value amount may not be recoverable. An impairment loss is recognized when the carrying amount of the asset exceeds the sum of the undiscounted cash flows resulting from its use and eventual disposition. The impairment loss is measured as the amount by which the carrying amount of the long lived assets exceeds its fair value.

Impairment charges would be included with costs and expenses in the Company's consolidated statements of operations, and would result in reduced carrying amounts of the related assets on the Company's consolidated balance sheets. No adjustments were made to long-lived assets during the period ended June 30, 2018, as a result of management's assessments.

XML

Note 2 - Basis of Presentation and Use of Estimates: I) Advertising (Policies)

6 Months Ended

Jun. 30, 2018

Policies

I) Advertising

i) Advertising

Advertising costs are charged to operations as incurred and are included in operating expenses. The amounts charged for the six month period ended June 30, 2018 and 2017 amounted to $38,174 and $50,885, respectively.

XML

Note 2 - Basis of Presentation and Use of Estimates: J) Revenue Recognition (Policies)

6 Months Ended

Jun. 30, 2018

Policies

J) Revenue Recognition

j) Revenue Recognition

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 606, Revenue From Contracts With Customers, effective for public business entities with annual reporting periods beginning after December 15, 2017.  This new revenue recognition standard (new guidance) has a five step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. The impact of the Company’s initial application of ASC 606 did not have a material impact on its financial statements and disclosures.

The Company’s consolidated financial statements are prepared under the accrual method of accounting. Revenues are recognized when persuasive evidence of an arrangement exists, services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. This occurs only when the product is ordered and subsequently shipped.

XML

Note 2 - Basis of Presentation and Use of Estimates: K) Income Taxes (Policies)

6 Months Ended

Jun. 30, 2018

Policies

K) Income Taxes

k) Income Taxes

The Company follows the provisions of ASC 740 10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740 10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company has no amounts accrued for interest or penalties as of June 30, 2018 and December 31, 2017, respectively.  The Company is no longer subject to examination by taxing authorities for years before December 31, 2014.  The company does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Company has received no notice of audit or any notifications from the IRS for any of the open tax years.

XML

Note 2 - Basis of Presentation and Use of Estimates: L) Net Loss Per Share (Policies)

6 Months Ended

Jun. 30, 2018

Policies

L) Net Loss Per Share

l) Net Loss Per Share

Basic loss per share excludes dilution and is computed by dividing the loss attributable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings of the Company.  Diluted loss per share is computed by dividing the loss available to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless consideration of such dilutive potential shares would result in anti-dilution.

XML

Note 2 - Basis of Presentation and Use of Estimates: M) Financial Instruments and Fair Value Measurements (Policies)

6 Months Ended

Jun. 30, 2018

Policies

M) Financial Instruments and Fair Value Measurements

m) Financial Instruments and Fair Value Measurements

The carrying value of the Company’s current consolidated financial instruments, which include cash and cash equivalents, accounts payable and accrued liabilities approximates their fair values because of the short term maturities of these instruments.

FASB ASC 820 Fair Value Measurement clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows:

• Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date.
• Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
• Level 3: Significant unobservable inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

XML

Note 2 - Basis of Presentation and Use of Estimates: O) Related Party Transactions (Policies)

6 Months Ended

Jun. 30, 2018

Policies

O) Related Party Transactions

o) Related Party Transactions

All transactions with related parties are in the normal course of operations and are measured at the exchange amount.

XML

Note 2 - Basis of Presentation and Use of Estimates: N) Recent Accounting Pronouncements (Policies)

6 Months Ended

Jun. 30, 2018

Policies

N) Recent Accounting Pronouncements

n) Recent Accounting Pronouncements

In February 2016, the FASB issued ASU 2016 02, Leases which, for operating leases, requires a lessee to recognize a right of use asset and a lease liability, initially measured at the present value of the lease payments, in its balance sheet. The standard also requires a lessee to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term, on a generally straight line basis. The ASU is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2016 02 is expected to result in the recognition of right to use assets and associated obligations on its balance sheet.

XML

Note 6 - Stockholders' Equity: Share-based Compensation, Stock Options, Activity (Tables)

6 Months Ended

Jun. 30, 2018

Tables/Schedules

Share-based Compensation, Stock Options, Activity

By Exercise Price:	June 30, 2018	December 31, 2017
Warrants - $0.35	2,750,000	2,750,000
Warrants - $0.50	9,275,000	14,342,000
Warrants - $0.75	114,286	114,286
Warrants - $1.00	124,999	124,999
Total outstanding	12,264,285	17,331,285

XML

Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)

6 Months Ended

Jun. 30, 2018

Tables/Schedules

Schedule of Future Minimum Rental Payments for Operating Leases

Fiscal Year Ending December 31
2018	$     116,657
2019	28,000
2020	167,981
2021	163,417
2022	168,310
Thereafter	548,430
Total	$ 1,285,487

XML

Note 4 - Convertible Debt (Details)	1 Months Ended
	Jan. 31, 2017 shares
Details
Stock Issued for Conversion of Debt	6,762,942

XML

Note 5 - Notes Payable - Related Party (Details)	1 Months Ended
	Jan. 31, 2017 USD ($) shares
Details
Debt Conversion, Converted Instrument, Shares Issued | shares	3,367,000
Debt Conversion, Original Debt, Amount | $	$ 841,750

XML

Note 6 - Stockholders' Equity (Details) - USD ($)	1 Months Ended
	Jun. 30, 2018	Apr. 30, 2018	Feb. 28, 2018	Jan. 31, 2018	Dec. 31, 2017
Details
Common Stock, Shares Authorized	499,990,000				499,990,000
Common Stock, Par Value	$ 0.0001				$ 0.0001
Common Stock, Shares Issued	86,767,020				81,448,561
Shares issued for services, Shares	1,200,000	449,300	500,000	900,000
Shares issued for services, Value	$ 240,000	$ 100,218	$ 140,000	$ 203,351
Stock Issued During Period Shares Issued For Past Services				100,000
Stock Issued During Period Value Issued For Past Services				$ 47,618
Stock Issued to Settle Accounts Payable			169,159
Stock Issued to Settle Accounts Payable, Value			$ 31,490
Stock Issued for the Acquisition of Production Equipment			2,000,000
Stock Issued for the Acquisition of Production Equipment, Value			$ 569,200

XML

Note 6 - Stockholders' Equity: Share-based Compensation, Stock Options, Activity (Details) - shares	Jun. 30, 2018	Dec. 31, 2017
Warrants $0.35
Class of Warrant or Right, Outstanding	2,750,000	2,750,000
Warrants $0.50
Class of Warrant or Right, Outstanding	9,275,000	14,342,000
Warrants $0.75
Class of Warrant or Right, Outstanding	114,286	114,286
Warrants $1.00
Class of Warrant or Right, Outstanding	124,999	124,999
Total Outstanding
Class of Warrant or Right, Outstanding	12,264,285	17,331,285

XML

Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Details
Operating Leases, Future Minimum Payments, Next Rolling Twelve Months							$ 116,657
Operating Leases, Future Minimum Payments, Due in Two Years						$ 28,000
Operating Leases, Future Minimum Payments, Due in Three Years					$ 167,981
Operating Leases, Future Minimum Payments, Due in Four Years				$ 163,417
Operating Leases, Future Minimum Payments, Due in Five Years			$ 168,310
Operating Leases, Future Minimum Payments, Due Thereafter		$ 548,430
Operating Leases, Future Minimum Payments Due	$ 1,285,487

XML

Note 7 - Commitments and Contingencies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Details
Operating Leases, Rent Expense	$ 39,515	$ 38,556